ARHGAP29 Antibodies

AND ARHGAP29 ELISA kits, ARHGAP29 Proteins

Many biological assays use antibodies to detect ARHGAP29, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with ARHGAP29 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop ARHGAP29 antibodies...

We validate the specificity of these antibodies to ARHGAP29 by testing them on tissues known to express ARHGAP29 positively and negatively. Browse below to find the ARHGAP29 antibody that suites your experiment. We have 2 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: CCN4 Next: MED21

ARHGAP29 Infographic by Boster Bio

All ARHGAP29 Products

Product

Figures

Specificity

Applications

Price

Rho GTPase activating protein 29 (ARHGAP29) (NM_004815) Human Recombinant Protein

$1249
Cat # PROTQ52LW3
20 µg

Rho GTPase activating protein 29 (ARHGAP29) (NM_004815) Human Over-expression Lysate

Human

$628
Cat # LS009411
100 µg

ARHGAP29 Overview

Facts about Rho GTPase-activating protein 29.

ARHGAP29 3D structure. Source: alphafold

Rho GTPase-activating protein 29 (ARHGAP29)

GTPase activator for the Rho-type GTPases by turning them into an inactive GDP-bound state. Has strong action toward RHOA, and weaker action toward RAC1 and CDC42.

May act as a specific effector of RAP2A to regulate Rho. In concert with RASIP1, suppresses RhoA signaling and dampens ROCK and MYH9 activities in endothelial cells and plays an essential role in blood vessel tubulogenesis.

Gene Information

Human
Gene Name:	ARHGAP29
Uniprot:	Q52LW3
Entrez:	9411

Family

Belongs to:

No superfamily

Alternative Names

PARG1PTPL1-associated RhoGAP 1 (PARG1); PTPL1-associated RhoGAP protein 1; Rho GTPase activating protein 29; rho GTPase-activating protein 29; Rho-type GTPase-activating protein 29; RP11-255E17.1

Molecular Weight

Mass (kDA):
142.064 kDA

Genomic Context


Human

Location:	1p22.1
Sequence:	1; NC_000001.11 (94168905..94275068, complement)

Tissue Specificity

Widely expressed. Highly expressed in skeletal muscle and heart. Expressed at intermediate level in placenta, liver and pancreas. Weakly expressed in brain, lung and kidney.

Diseases

Malignant Neoplasms
Neoplasms
Lymphoma
Malignant Lymphoma, Lymphocytic, Intermediate Differentiation, Diffuse
Cell Transformation, Neoplastic
Tissue Adhesions
Radiation Injury
Colonic Neoplasms
Malignant Tumor Of Colon
Bone Neoplasms
Carcinoma

Osteosarcoma
Mammary Neoplasms
Cytogenetic Abnormality
Cleft Lip
Porcine Reproductive And Respiratory Syndrome

Pathways

Cell Adhesion
Methylation
Cell Division
Gastrulation
Circadian Rhythm
Cell Cycle
S Phase
Aging
Cell Growth

Blood Vessel Morphogenesis
Pathogenesis
Localization

PTMs

Phosphorylation

Methylation

Research Areas

Signal Transduction

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/ARHGAP29

References

PMID: 9305890 by Saras J., et al. A novel GTPase-activating protein for Rho interacts with a PDZ domain of the protein-tyrosine phosphatase PTPL1.

PMID: 11716068 by Mariani L., et al. Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis.